ACTION Registry®–GWTG™ is a national, risk-adjusted, outcomes-based quality improvement program that helps participating facilities measure and improve care for high-risk ACS patients with STEMI and NSTEMI. The result of the collaboration between the two leading national coronary artery disease registries, the NCDR® ACTION Registry® and the American Heart Association (AHA) Get With The GuidelinesSM-CAD Registry, ACTION Registry–GWTG will be the largest, most comprehensive national cardiovascular patient database ever developed by the medical profession.
Combining the strengths of the two programs, ACTION Registry–GWTG will collect a comprehensive set of data elements that provide healthcare professionals and their facilities with the information they need to monitor and improve adherence to the most current, science-based ACC/AHA treatment guidelines. Participation will greatly facilitate quality improvement efforts, optimize clinical care, and improve clinical outcomes for acute coronary syndrome patients.
Visit How To Join to request additional information or to download an enrollment package. Or, visit the ACTION website for more information.
No upcoming events. Sign-up below for event updates.
Optimal Therapy For Hypertensive Emergencies, Heart Failure, Stroke, And Understanding The Impact Of The Obesity Epidemic
FORMAT: Slides with audio via web EVENT DATE: Tuesday November 9, 2010 Available On-Demand:View On-line Now
Presentations:
Obesity: The Highly Visible Killer. Andra L. Blomkalns, MD; Assistant Professor and Vice-Chair, Academic Affairs, Department of Emergency Medicine, University of Cincinnati College of Medicine
Treating Acute and Hemorrhagic Stroke – What is the "State of the Art"?. Arthur M. Pancioli, MD; Richard C. Levy Professor and Chairman, Department of Emergency Medicine, University of Cincinnati College of Medicine; Member, Greater Cincinnati/N. Kentucky Stroke Team
Hypertensive Emergencies: Optimal Therapy in the ED. Phillip D. Levy, MD, MPH; Associate Director of Clinical Research, Department of Emergency Medicine, Wayne State University, Detroit, Michigan Associate Professor, Wayne State University School of Medicine, Detroit, Michigan
Management of Acute Heart Failure in the Emergency Department. Alan B. Storrow, MD; Vice Chair for Research and Academic Affairs, Vanderbilt University, Department of Emergency Medicine, Nashville, TN
Optimizing Care For Patients With ACS In The Emergency Department (Webcast)
FORMAT: Slides with audio via web EVENT DATE: Tuesday October 19, 2010 Available On-Demand:View On-line Now
Presentations:
Risk Stratification of Acute Coronary Syndrome in the Emergency Department. W. Brian Gibler, MD; President & Chief Executive Officer of University Hospital, Cincinnati, OH; Professor, Department of Emergency Medicine, University of Cincinnati College of Medicine
Anti-Coagulant Therapy for ACS: Optimal Care in the ED. Charles V. Pollack, MD; Professor and Chairman; Department of Emergency Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA
Optimal Use of Thienopyridine Anti-platelet Therapy for ACS. James W. Hoekstra, MD; Professor and Chairman; Wake Forest University, Winston Salem, NC
Controversies in the ED Use Anti-platelet Therapy for ACS. Deborah B. Diercks, MD; Associate Professor, Department of Emergency Medicine, UC Davis Medical Center, Sacramento, CA
It is our hope that this material will provide emergency physicians with information necessary to improve and facilitate care for this unique patient
population.
ACEP 2010 Audiocast: Optimizing Care For Patients With ACS In The Emergency Department
FORMAT: Audiocast via the web EVENT DATE: September 29, 2010 Available On-Demand:Listen On-line Now
Presentations:
Risk Stratification of Acute Coronary Syndrome in the Emergency Department. W. Brian Gibler, MD; President & Chief Executive Officer of University Hospital, Cincinnati, OH; Professor, Department of Emergency Medicine, University of Cincinnati College of Medicine
Anti-Coagulant Therapy for ACS: Optimal Care in the ED. Charles V. Pollack, MD; Professor and Chairman; Department of Emergency Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA
Optimal Use of Thienopyridine Anti-platelet Therapy for ACS. James W. Hoekstra, MD; Professor and Chairman; Wake Forest University, Winston Salem, NC
Controversies in the ED Use Anti-platelet Therapy for ACS. Deborah B. Diercks, MD; Associate Professor, Department of Emergency Medicine, UC Davis Medical Center, Sacramento, CA
It is our hope that this material will provide emergency physicians with information necessary to improve and facilitate care for this unique patient
population.
ACEP 2009 EMCREG Symposium: Cardiovascular and Neurovascular Emergencies
Miss us at ACEP 2009? Complimentary Webcast Available On-line!
View all the Presentations On-line! Please feel to view the webcasts of each presentation. These webcasts are complimentary and includes CME for those who register before viewing.
ST-segment Elevation Myocardial Infarction (STEMI): Optimal Antiplatelet and Antithrombotic Therapy in the Emergency Department
James W. Hoekstra, MD Novel Antiplatelet and Antithrombin Therapy for Acute Coronary Syndromes: STEMI and NSTEMI Optimal Antiplatelet and Antithrombotic Therapy in the
Emergency Department
W. Brian Gibler, MD American Heart Association Mission Lifeline: Developing a STEMI Regional Care System
Deborah B. Diercks, MD Ideal Management of Acute Heart Failure Syndromes in the Emergency Department
Judd E. Hollander, MD Cadvanced Stroke Care: Avoiding Medical-Legal Disasters in the Emergency Department
Arthur M. Pancioli, MD
It is our hope that this material will provide emergency physicians with information necessary to improve and facilitate care for this unique patient
population.
ACEP 2008 EMCREG Symposia: Cardiovascular and Neurovascular Emergencies
View all the Presentations On-line! Please feel to view the webcasts of each presentation. These webcasts are free of charge and includes CME for those who register before viewing.
The New 2007 ACC/AHA Guidelines: Optimum Antiplatelet and Antithrombin Management in NSTE-ACS
Charles V. Pollack, MD Focused Update on the 2007 STEMI ACC/AHA STEMI Guidelines: Implications for ED Practice
James E. Hoekstra, MD Evolving Therapies for ACS: Moving Forward with Novel Antiplatelet and Anti-thrombin Treatment
Deborah B. Diercks, MD Advances in Point-of-Care Testing for Chest Pain Centers: Impact on ACS and Heart Failure Diagnosis
J. Lee Garvey, MD Case Studies: Rapid Diagnosis and Optimal Therapy for ACS and Heart Failure
Charles V. Pollack, MD; James W. Hoekstra, MD; Deborah B. Diercks, MD; and J. Lee Garvey, MD Evaluation and Treatment of Hypertension in the ED
W. Brian Gibler, MD Advances in the Diagnosis and Treatment of Stroke
Arthur M. Pancioli, MD Acute Heart Failure Syndromes – Stratifying Patients According to Risk
J. Douglas Kirk, MD Evolving Therapy for Heart Failure: Novel Approaches to Management in the ED
Sean P. Collins, MD State of the Art Early Detection and Treatment of DVT and Pulmonary Embolism
Charles B. Carins, MD
It is our hope that this material will provide emergency physicians with information necessary to improve and facilitate care for this unique patient
population.
ACEP 2007 EMCREG Symposia: Cardiovascular, Neurovascular and Infectious Emergencies
Miss us at ACEP 2007?
View all the Presentations On-line! Please feel to view the webcasts of each presentation. These webcasts are free of charge and includes CME for those who register before viewing.
These symposia represented a unique opportunity to hear and interact with experts in emergency cardiovascular, neurovascular and infectious care and to gain up-to-date knowledge on the full spectrum of decision-making and care for patients with stroke and TIA, acute heart failure, hypertensive emergencies, acute coronary syndromes (ACS) including non-ST-segment elevation MI (NSTEMI) and ST-segment elevation myocardial infarction (STEMI), severe bacterial infections, and venous thromboembolism (DVT and PE).
It is our hope that this material will provide emergency physicians with information necessary to improve and facilitate care for this unique patient
population.
The following CME-certified webcasts are provided as an educational service by CMEducation Resources, LLC, an award-winning organization devoted to providing national expert-based, scientifically rigorous programming focused on cardiovascular disease for the emergency medicine and critical care specialist.
Program Overview:
VTE is considered the most prevalent preventable cause of death during hospitalization, with approximately one out of ten hospital deaths being ascribed to PE. Yet, appropriate preventive measures continue to be under-prescribed, especially in the CV setting, even though safe and effective prophylactic measures are now widely available for patients with a broad range of CV conditions including CAD, heart failure, ACS, and related condition. Samuel Z. Goldhaber, MD, chairs an international congress symposium on new frontiers in the science and medicine of VTE, with a focus on the CV environment.
Deepak Bhatt, MD, of Harvard Medical School and the VA Boston Healthcare System, examines the evidence, guidelines, and recent studies on oral antiplatelet therapy in the front lines of cardiovascular practice, with a special emphasis on the myths and truths of drug interactions with PPIs.
Peter Libby, MD, FACC, Chief of Cardiovascular Medicine at Brigham and Women’s Hospital, chairs an expert faculty as they study the latest developments and landscape changes in atrial fibrillation, focusing on emerging strategies for stroke prevention.
There has been growing interest in identifying oral anticoagulants that can achieve safe and effective prophylaxis for stroke prevention, with minimal risk of bleeding and without the need for monitoring of clotting parameters. Samuel Z. Goldhaber, MD, of Harvard Medical School, leads an expert faculty in discussing the latest strategies for stroke prevention in the setting of atrial fibrillation, reviews the latest American College of Chest Physicians and ACC/AHA Guidelines for stroke prevention, and analyzes recent landmark clinical trials in anticoagulation.
Program Chairman Samuel Z. Goldhaber, MD, of Harvard Medical School, leads an international panel of cardiologists and thrombosis experts in The iQ&A Interactive Medical Intelligence Zone for DVT and PE. Dr. Goldhaber and this world forum of experts answer the most frequently asked questions about the role of low molecular weight heparins in the prevention of DVT and PE across the arteriovenous risk spectrum.
Program Chairman Samuel Z. Goldhaber, MD, of Harvard Medical School, leads an international panel of cardiologists and thrombosis experts in The iQ&A Interactive Medical Intelligence Zone for Thrombosis Management. Dr. Goldhaber and this world forum of experts address the most pressing questions on advances in anticoagulation-based therapy in the setting of atrial fibrillation, VTE and heart disease.
Optimal Therapy For Hypertensive Emergencies, Heart Failure, Stroke, And Understanding The Impact Of The Obesity Epidemic
Available On-Demand:
Optimizing Care For Patients With ACS In The Emergency Department (Webcast)
ACEP 2010 Audiocast:
